Research Article

Clinical Characteristics and Treatment Outcomes of Patients Undergoing Autologous Blood Pleurodesis: A Retrospective Observational Study

Volume: 47 Number: 3 September 30, 2025
EN TR

Clinical Characteristics and Treatment Outcomes of Patients Undergoing Autologous Blood Pleurodesis: A Retrospective Observational Study

Abstract

Abstract Objective: This retrospective study aimed to evaluate the demographic characteristics, clinical outcomes, and success rates of patients who underwent autologous blood pleurodesis at our institution between 2020 and 2025. Methods: A total of 66 patients who received autologous blood pleurodesis between January 2020 and December 2025 were included. Data including age, sex, indication for pleurodesis, comorbidities, hospital length of stay, and time to clinical stabilization were collected. Subgroup comparisons of stabilization time were conducted using the Mann–Whitney U test. Results: The mean age of patients was 56.8 ± 18.7 years, and 75.8% were male. The most common indication was prolonged air leak (34.8%), followed by pleural effusion (30.3%) and postoperative air leak (15.2%). The mean hospital stay was 19.2 ± 12.8 days, and the mean time to clinical stabilization was 5.0 ± 4.3 days. Although patients with chylothorax had a longer stabilization time (9.3 ± 3.1 days) compared to those with pleural effusion, the difference was not statistically significant (p = 0.174). Conclusion: Autologous blood pleurodesis appears to be a safe, effective, and cost-efficient option for various pleural pathologies, particularly in patients with contraindications to chemical agents or in whom conservative measures have failed.

Keywords

References

  1. 1. Apilioğulları B, Dumanlı A, Ceran S. Application of autologous blood patch in patients with non-expanded lungs and persistent air leak. Turk J Thorac Cardiovasc Surg. 2020;28(3):3407.
  2. 2. Dugan KC, Laxmanan B, Murgu S, Hogarth DK. Management of persistent air leaks. Chest. 2017;152(2):417-423.
  3. 3. Lai Y, Zheng X, Yuan Y, Xie TP, Zhao YF, Zhu ZJ, Hu Y. A modified pleurodesis in treating postoperative chylothorax. Ann Transl Med. 2019;7(20):549.
  4. 4. Mierzejewski M, Korczynski P, Krenke R, Janssen JP. Chemical pleurodesis – A review of mechanisms involved in pleural space obliteration. Respir Res. 2019;20:247.
  5. 5. Marcoux M, Slate J, Majid A. Talc pleurodesis in pleural disease. Pleura. 2019;6:7-42.
  6. 6. Zhou J. A review of the application of autologous blood transfusion. Braz J Med Biol Res. 2016;49(9):e5493.
  7. 7. Brunelli A, Varela G. Prediction of air leak duration after pulmonary lobectomy: a prospective, multicenter study. Ann Thorac Surg. 2007;84(5):1571-1577.
  8. 8. Cerfolio RJ, Bryant AS. The management of air leaks. Thorac Surg Clin. 2008;20(3):379-385.

Details

Primary Language

English

Subjects

Health Services and Systems (Other)

Journal Section

Research Article

Publication Date

September 30, 2025

Submission Date

June 7, 2025

Acceptance Date

September 11, 2025

Published in Issue

Year 2025 Volume: 47 Number: 3

AMA
1.Temel U. Clinical Characteristics and Treatment Outcomes of Patients Undergoing Autologous Blood Pleurodesis: A Retrospective Observational Study. CMJ. 2025;47(3):17-21. doi:10.7197/cmj.1715686